RBC boosted the price target for Cidara Therapeutics to $75.
1 report, 0 independent
Updated Jun 24
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
RBC boosted the price target for Cidara Therapeutics to $75.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Cidara Therapeutics
company in San Diego, United States
Nothing else this week.
-
Royal Bank of Canada
financial institution in Canada
Related events
- RBC raised price target for AutoCanada stock on August 18, 2026.
- RBC raised the price target on Range Resources in July 2025.
- Royal Bank of Canada raised its price target on Webster Financial on July 2, 2025.
- RBC raised its target price for Howmet Aerospace, while Citigroup reiterated a 'buy' rating on the shares.
- Royal Bank of Canada raised its target price on USA Compression Partners, LP on June 7, 2026.
Coverage
Newest first; wire copies grouped- Unknown outlet